Zhouxian Pan

Dr. Zhouxian Pan

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2019 in BMJ Open
Verified
Journal Article
Open access
PDF file
ZPZhouxian Pan
Zhouxian Pan
JCJiantao Cui
Jiantao Cui
GSGuangliang Shan
Guangliang Shan
YCYuyu Chou
Yuyu Chou
LPLi Pan
Li Pan
YZYong Zhong
Yong Zhong
Aims To investigate the prevalence, ethnic differences and associated risk factors for pterygium in Han and Manchu populations aged 40–79 years in Hebei province, China. Design Cross-sectional study, as a part of the China National Health Survey. Setting Hebei province, China. Participants A multistage cluster sampling method with urbanisation level-based stratification was used to select participants for this study. A total of 4591 individuals over 40 years were recruited for this study. Inclusive criteria: (1) residents who had been living in Hebei for more than 1 year; (2) Han individuals with both parents being Han, or Manchu individuals with both parents being Manchu; (3) underwent ophthalmic examinations and (4) information in the questionnaire was complete. Main outcome measures Multiple logistic regression analysis was used to evaluate the association between pterygium prevalence and factors of interest. Results A total of 3790 individuals (2351 Hans and 1439 Manchus) met the study criteria, of which 248 were diagnosed with pterygium (6.5%). There was no significant difference between the prevalence rates in Hans (6.2%) and Manchus (7.2%) (p=0.232). Multivariate analysis revealed that the risk factors for grade 2 or higher pterygium were increasing age (p<0.001) and rural residence (OR 1.83; 95% CI 1.11 to 3.02; p=0.018), while the protective factors include gender (female) (OR 0.58; 95% CI 0.37 to 0.88; p=0.011), cigarette smoking (OR 0.53; 95% CI 0.34 to 0.83; p=0.005) and myopia (OR 0.50; 95% CI 0.33 to 0.77; p=0.002). Premature menopause (OR 2.66; 95% CI 1.05 to 6.72; p=0.038) increased the risk of grade 2 or higher pterygium in females, while higher high-density lipoprotein (HDL) (OR 1.94; 95% CI 1.08 to 3.47; p=0.027) was a risk factor of grade 2 or higher pterygium in males. Conclusion The overall prevalence of pterygium in Han and Manchu population in Hebei, China was approximately 6.1%. There were no differences in the prevalence of pterygium between Hans and Manchus, and the race was not a risk factor. This is the first study to report on the positive association between premature menopause and pterygium in females and between higher HDL levels and pterygium in males.

19 February 2021 in Clinical Reviews in Allergy & Immunology
Verified
Journal Article
Closed access
PDF file
YSYue Shi
Yue Shi
RTRui Tang
Rui Tang
FLFangmei Luo
Fangmei Luo
HLHong Li
Hong Li
ZPZhouxian Pan
Zhouxian Pan
TPThomas A. Platts-Mills
Thomas A. Platts-Mills

27 January 2021 in Contact Dermatitis
Verified
Journal Article
Closed access
PDF file
ZPZhouxian Pan
Zhouxian Pan
JDJuncai Dong
Juncai Dong
Jin-Lyu SunJin-Lyu Sun
Jin-Lyu Sun
JZJing Zhang
Jing Zhang
CCChristopher Chang
Christopher Chang
RTRui Tang
Rui Tang

27 February 2025 in Allergy Medicine
Verified
Journal Article
Open access
JZJing Zhang
Jing Zhang
ZPZhouxian Pan
Zhouxian Pan
SZShisu Zhao
Shisu Zhao
JLJihan Li
Jihan Li
Jin-Lyu SunJin-Lyu Sun
Jin-Lyu Sun

1 January 2026 in Research
Verified
Journal Article
Open access
LCLin Chen
Lin Chen
ZPZhou-Xian Pan
Zhou-Xian Pan
ZMZi-Qi Ma
Zi-Qi Ma
YJYu-Xuan Jin
Yu-Xuan Jin
YRYi Ru
Yi Ru
Jin-Lyu SunJin-Lyu Sun
Jin-Lyu Sun
The understanding of type 2 inflammatory diseases is undergoing a paradigm shift from “immune imbalance” toward “immune–metabolic crosstalk”. Energy metabolism not only fuels immune responses but also fundamentally dictates the functional phenotypes of immune cells through metabolic reprogramming. By systematically integrating metabolic programming data of key immune cells across diverse tissues (skin, gut, nasal, and ocular mucosa), this review constructs a cross-disease “metabolism–signaling network” atlas. The synthesis highlights that glycolysis and mTORC1 signaling are predominantly coupled with the pro-inflammatory outputs of Th2 cells and ILC2s, whereas fatty acid oxidation (FAO) and oxidative phosphorylation (OXPHOS) sustain the homeostasis of Tregs and M2-like macrophages. Furthermore, this review characterizes how the tryptophan, glutamine, and arginine pathways fine-tune the immune tolerance boundary via the IDO–AhR–mTOR axis. We also elucidate a conserved inter-organ “hypoxia–HIF-1α–lactylation” axis, which, in conjunction with tissue-specific metabolic branches (e.g., the ceramide pathway in the skin, the SCFA circuit in the gut, and the lactate–GPR81 loop in the mucosa), collectively sculpts local microenvironments and remodeling trajectories. Ultimately, a novel diagnostic and therapeutic framework centered on metabolic phenotyping is proposed, providing prospective insights into targeting metabolic checkpoints for precision immunotherapy in type 2 inflammation.

13 October 2026 in Allergy
Verified
Journal Article
Open access
ZPZhouxian Pan
Zhouxian Pan
ZDZhirong Du
Zhirong Du
JLJanice A. Layhadi
Janice A. Layhadi
BYBin Yang
Bin Yang
MTMingle Tian
Mingle Tian
MSMohamed H. Shamji
Mohamed H. Shamji